Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

ObjectivePlasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver c...

詳細記述

保存先:
書誌詳細
主要な著者: Chu-Lin Chou, Shu-Hui Juan, Ching-Hao Li, Hsi-Hsien Chen, Chih-Chin Kao, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2022-05-01
シリーズ:Frontiers in Oncology
主題:
DPP-4 inhibitors
colorectal cancer
liver cancer
second-line agents
type 2 diabetes mellitus
オンライン･アクセス:https://www.frontiersin.org/articles/10.3389/fonc.2022.840142/full
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料